Compare BNL & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNL | TMDX |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.8B |
| IPO Year | 2008 | 2019 |
| Metric | BNL | TMDX |
|---|---|---|
| Price | $19.89 | $98.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $20.22 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 3.8M | 801.7K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.87% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | 0.50 | ★ 4.87 |
| Revenue | $454,138,000.00 | ★ $605,494,000.00 |
| Revenue This Year | $7.93 | $24.25 |
| Revenue Next Year | $5.45 | $18.75 |
| P/E Ratio | $39.75 | ★ $20.18 |
| Revenue Growth | 5.17 | ★ 37.13 |
| 52 Week Low | $15.28 | $89.10 |
| 52 Week High | $20.48 | $156.00 |
| Indicator | BNL | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 54.21 | 36.48 |
| Support Level | $19.72 | $93.08 |
| Resistance Level | $20.48 | $120.60 |
| Average True Range (ATR) | 0.33 | 5.22 |
| MACD | -0.03 | -0.84 |
| Stochastic Oscillator | 27.01 | 8.54 |
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.